Cost‐Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Cost‐Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States

Authors:	Patrick M. Zueger Varun M. Kumar Rachel L. Harrington Gianna C. Rigoni Alicia Atwood Robert J. DiDomenico Daniel R. Touchette

Affiliation:	1. Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois;2. Institute for Clinical and Economic Review, Boston, Massachusetts;3. Economics Department, University of Illinois at Chicago, Chicago, Illinois;4. Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois;5. Center for Pharmacoepidemiology and Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois

Abstract:

Keywords:	sacubitril‐valsartan cost‐effectiveness heart failure with reduced ejection fraction quality‐adjusted life year